Can infections trigger glomerulonephritis, and what are the common infectious causes and recommended management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Infection-Triggered Glomerulonephritis: Diagnosis and Management

Yes, infections definitively cause glomerulonephritis through immune complex deposition, with the primary treatment being control of the underlying infection combined with supportive management of the nephritic syndrome. 1

Pathophysiology and Mechanism

Infections trigger glomerulonephritis through deposition of antigen-antibody immune complexes in glomerular tissue, causing inflammation and kidney damage. 1, 2 This is an immunologically mediated glomerular injury that may occur during active infection (para-infectious) or after a variable latent period (post-infectious). 3

Common Infectious Causes

Viral Infections

  • Hepatitis C (including HCV-associated mixed cryoglobulinemia) 1
  • Hepatitis B 1
  • COVID-19 (can exacerbate IgA nephropathy) 4
  • Herpes simplex virus (HSV) 4

Bacterial Infections

  • Streptococcal infections (pharyngitis occurring 1-2 weeks prior, or impetigo 4-6 weeks prior) - the classic prototype 2, 3
  • Staphylococcal infections (increasingly common in adults, particularly elderly and diabetics) 5, 6, 7
  • Endocarditis 1
  • Infected ventriculo-atrial shunt 1
  • Visceral abscesses 1
  • Bartonella (can cause endocarditis) 4

Protozoal/Other Infections

  • Malaria, schistosomiasis, mycoplasma, leishmaniasis, filariasis, histoplasmosis 1

Diagnostic Approach

Essential Laboratory Workup

  • Complement studies: Low C3 is the hallmark finding (should normalize within 8-12 weeks); C4 typically remains normal 2, 5
  • Streptococcal serology: Anti-streptolysin O (ASO), anti-DNAse B, and anti-hyaluronidase antibodies 2, 5
  • Urinalysis: Glomerular hematuria with red blood cell casts and proteinuria (measure albumin-creatinine or protein-creatinine ratio) 2
  • Kidney function tests: Serum creatinine and eGFR 2

Critical Diagnostic Pitfall

If C3 remains low beyond 12 weeks, perform kidney biopsy immediately to exclude complement C3 glomerulonephritis (C3GN), which requires different management. 5, 2 Before diagnosing idiopathic immune complex glomerulonephritis, concurrent or preceding infection must be excluded. 1

When to Perform Kidney Biopsy

  • Diagnosis uncertain or atypical presentation 2
  • C3 persistently low beyond 12 weeks 5, 2
  • Rapidly progressive glomerulonephritis with crescentic features 2
  • Normal ASO but high clinical suspicion (measure alternative streptococcal antibodies) 2

Treatment Algorithm

Step 1: Antibiotic Therapy (Even Without Active Infection)

Administer antibiotics to reduce antigenic load, even when active infection is no longer present. 5, 2 This is critical and often missed—the goal is NOT to treat active infection but to decrease streptococcal antigenic burden. 2

For post-streptococcal glomerulonephritis:

  • First-line: Penicillin 5, 2
  • Penicillin allergy (non-anaphylactic): Erythromycin or first-generation cephalosporins (e.g., cephalexin) 5, 2
  • Severe infections or resistant organisms: Third-generation cephalosporins (e.g., ceftriaxone) 5, 2
  • Alternative: Co-amoxiclav (amoxicillin/clavulanate) provides excellent streptococcal coverage 2

For endocarditis-related glomerulonephritis:

  • Continue antibiotics for 4-6 weeks (hematuria, proteinuria, and azotemia may persist for months after infection eradication) 5

During outbreaks:

  • Use systemic antimicrobials to eliminate nephritogenic strains of Streptococcus pyogenes from the community 2

Step 2: Supportive Management of Nephritic Syndrome

This is the cornerstone of treatment and directly impacts morbidity and quality of life. 5

Fluid and Blood Pressure Management:

  • Restrict dietary sodium to <2.0 g/day (<90 mmol/day) as first-line intervention 5, 2
  • Use diuretics as first-line agents for both fluid overload and hypertension 5, 2
  • Target blood pressure: <130/80 mmHg (or <125/75 mmHg if proteinuria >1 g/day) 5
  • Monitor closely for diuretic complications: hyponatremia, hypokalemia, GFR reduction, and volume depletion 5, 2

Additional Supportive Measures:

  • Treat metabolic acidosis if serum bicarbonate <22 mmol/L 5, 2
  • Restrict dietary protein to 0.8-1 g/kg/day if nephrotic-range proteinuria is present 2
  • Provide dialysis if necessary for severe acute kidney injury with uremia, refractory fluid overload, or life-threatening hyperkalemia 2

Step 3: Immunosuppressive Therapy (Rarely Indicated)

Corticosteroids should be considered ONLY for severe crescentic glomerulonephritis with rapidly progressive renal failure. 5, 2 The evidence for this is anecdotal and weak. 5

Critical Contraindication: Do NOT use corticosteroids for IgA-dominant post-infectious glomerulonephritis (typically occurs with staphylococcal infections, including MRSA, particularly in elderly and diabetic patients), as this can worsen the infection. 5, 2

Monitoring and Follow-Up

  • Assess C3 complement levels at diagnosis and serially—should normalize within 8-12 weeks in uncomplicated cases 5
  • If C3 remains low beyond 12 weeks: Perform kidney biopsy to exclude C3GN 5, 2
  • Monitor regularly: Kidney function, blood pressure, proteinuria, and hematuria throughout disease course 5, 2
  • Serial absolute lymphocyte counts if immunosuppression is used 8

Special Populations and Considerations

Adults vs. Children

The epidemiology has shifted dramatically over the past 3 decades. 7 In adults, infection-related glomerulonephritis is more likely to be:

  • Secondary to non-streptococcal infections (particularly staphylococcal) 7
  • Para-infectious (occurring during active infection) rather than post-infectious 6
  • Associated with occult infections in elderly patients with multiple comorbidities 6
  • Less likely to recover renal function, especially in elderly and diabetics 7

IgA-Dominant Infection-Related Glomerulonephritis

This is an increasingly recognized entity in older patients with staphylococcal infections (skin, endocarditis, or deep-seated infections). 2 It presents with similar nephritic features but shows IgA dominance on immunofluorescence rather than traditional subepithelial humps. 2 Kidney biopsy is essential for diagnosis when clinical presentation is atypical. 2

Common Clinical Pitfalls to Avoid

  1. Withholding antibiotics when active infection is no longer evident—the goal is to reduce antigenic load, not treat active infection 2
  2. Routinely using immunosuppression—most cases are self-limited and resolve spontaneously 2
  3. Using corticosteroids in IgA-dominant post-infectious GN—this worsens infection 2, 8
  4. Failing to perform kidney biopsy when C3 remains low beyond 12 weeks—this may represent C3GN requiring different management 5, 2
  5. Delaying screening for latent infections before starting immunosuppression (if needed for other indications) 8

Prognosis

Post-streptococcal glomerulonephritis in children is typically self-limiting with excellent prognosis. 3 However, bacterial, viral, and parasitic infections in adults may be associated with significant morbidity and long-term consequences, particularly in elderly and diabetic patients who may not recover renal function. 3, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Post-Streptococcal Glomerulonephritis (PSGN)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Post-Infectious Glomerulonephritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Infections-associated Glomerulonephritis].

Deutsche medizinische Wochenschrift (1946), 2020

Guideline

Antibiotic Prophylaxis in Glomerulonephritis Patients Starting Immunosuppression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.